Switching from Gilenya to Lemtrada could trigger MS activity

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

Switching from Gilenya to Lemtrada could trigger MS activity

Post by MSUK »

Switching from Gilenya to Lemtrada could trigger MS activity

According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Campath (Lemtrada, Alemtuzumab)”